K. P. . Pyar, “Efficacy, Safety of Baricitinib plus Remdesivir versus Standard Therapy (Remdesivir) in Patients with Severe COVID-19 Infection in Third Wave of Epidemics in Myanmar: Case Control Study”, International Journal Of Medical Science And Clinical Research Studies, vol. 2, no. 3, pp. 237–246, Mar. 2022.